120 related articles for article (PubMed ID: 836942)
1. Determination of phenylbutazone, tolbutamide and metabolites in plasma and urine using chemical ionization mass spectrometry.
Weinkam RJ; Rowland M; Meffin PJ
Biomed Mass Spectrom; 1977 Feb; 4(1):42-7. PubMed ID: 836942
[TBL] [Abstract][Full Text] [Related]
2. Interaction of phenylbutazone and tolbutamide in man.
Szita M; Gachályi B; Tornyossy M; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
Pond SM; Birkett DJ; Wade DN
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
[TBL] [Abstract][Full Text] [Related]
4. The use of solid probe chemical ionization mass spectrometry and gas chromatography-chemical ionization mass spectrometry in quantitation of drugs in biological fluids. Determination of tolbutamide and its metabolites in human plasma.
Matin SB; Knight JB
Biomed Mass Spectrom; 1974 Oct; 1(5):323-8. PubMed ID: 4465000
[No Abstract] [Full Text] [Related]
5. Mechanism of interaction of tolbutamide and phenylbutazone in diabetic patients.
Ober KF
Eur J Clin Pharmacol; 1974 Jul; 7(4):291-4. PubMed ID: 4853129
[No Abstract] [Full Text] [Related]
6. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
[TBL] [Abstract][Full Text] [Related]
7. Simple high-performance liquid chromatographic method for the determination of tolbutamide and its metabolites in human plasma and urine using photodiode-array detection.
Csillag K; Vereczkey L; Gachályi B
J Chromatogr; 1989 May; 490(2):355-63. PubMed ID: 2768408
[TBL] [Abstract][Full Text] [Related]
8. [Interaction of phenylbutazone and tolbutamide in man].
Szita M; Gachályi B; Tornyossy M; Káldor A
Orv Hetil; 1979 Nov; 120(47):2843-4. PubMed ID: 394087
[No Abstract] [Full Text] [Related]
9. Drug absorption, metabolism, and excretion. 8. Determination of tolbutamide and its metabolites in blood and urine.
Shibasaki J; Konishi R; Ueki T; Morishita T
Chem Pharm Bull (Tokyo); 1973 Aug; 21(8):1747-53. PubMed ID: 4756819
[No Abstract] [Full Text] [Related]
10. Simultaneous determinations of tolbutamide and its hydroxy and carboxy metabolites in serum and urine: application to pharmacokinetic studies of tolbutamide in the rat.
St-Hilaire S; Belanger PM
J Pharm Sci; 1989 Oct; 78(10):863-6. PubMed ID: 2600795
[TBL] [Abstract][Full Text] [Related]
11. Drug interactions in the horse: effect of furosemide on plasma and urinary levels of phenylbutazone.
Roberts BL; Blake JW; Tobin T
Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):257-65. PubMed ID: 981785
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.
Jetter A; Kinzig-Schippers M; Skott A; Lazar A; Tomalik-Scharte D; Kirchheiner J; Walchner-Bonjean M; Hering U; Jakob V; Rodamer M; Jabrane W; Kasel D; Brockmöller J; Fuhr U; Sörgel F
Eur J Clin Pharmacol; 2004 May; 60(3):165-71. PubMed ID: 15045499
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of tolbutamide and its metabolites in human plasma and urine by high-performance liquid chromatography and UV detection.
Hansen LL; Brøsen K
Ther Drug Monit; 1999 Dec; 21(6):664-71. PubMed ID: 10604830
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
Marunaka T; Shibata T; Minami Y; Umeno Y
J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
[TBL] [Abstract][Full Text] [Related]
15. Microdose pharmacogenetic study of ¹⁴C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism.
Ikeda T; Aoyama S; Tozuka Z; Nozawa K; Hamabe Y; Matsui T; Kainuma M; Hasegawa S; Maeda K; Sugiyama Y
Eur J Pharm Sci; 2013 Jul; 49(4):642-8. PubMed ID: 23727057
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
Zhang S; Song N; Li Q; Fan H; Liu C
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine.
Thiessen JJ; Rowland M
J Pharm Sci; 1977 Aug; 66(8):1063-70. PubMed ID: 894490
[TBL] [Abstract][Full Text] [Related]
18. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
[TBL] [Abstract][Full Text] [Related]
19. Plasma and urine levels of phenylbutazone in the horse.
Piperno E; Ellis DJ; Getty SM; Brody TM
J Am Vet Med Assoc; 1968 Jul; 153(2):195-8. PubMed ID: 5655055
[No Abstract] [Full Text] [Related]
20. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
Tobin T; Blake JW; Valentine R
Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
